Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world.[1][2]
ProductsThe company operates in agorchemicals, including insecticides, weedicides, fungicides, fumigants, rodenticides, plant growth nutrition products, bio-rationals, and plant growth regulators. It markets proprietary products from its Japanese parent, Sumitomo Chemical Co., in agrochemicals, animal nutrition, and environmental health.[1]The products comprise conventional chemistry sourced from SCC, and biological products sourced from a USA-based subsidiary, Valent Biosciences LLC.[2]
| S.No. | Name | Current Price (Rs.) | Price to Earning | Market Capitalization (Rs.Cr.) | Dividend yield (%) | Net Profit latest quarter (Rs.Cr.) | YOY Quarterly profit growth (%) | Sales latest quarter (Rs.Cr.) | YOY Quarterly sales growth (%) | Return on capital employed (%) | Sales (Rs.Cr.) | OPM (%) | Profit after tax (Rs.Cr.) | Profit after tax latest quarter (Rs.Cr.) | Price to book value | Return on assets (%) | Debt to equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | UPL | 799.30 | 28.41 | 67406.47 | 0.75 | 612.00 | 209.91 | 12019.00 | 8.38 | 7.66 | 47715.00 | 17.15 | 2372.46 | 484.10 | 2.11 | 0.95 | 0.94 |
| 2. | P I Industries | 3275.50 | 32.86 | 49695.27 | 0.49 | 409.30 | -19.46 | 1872.30 | -15.70 | 22.86 | 7460.70 | 27.18 | 1512.50 | 409.30 | 4.59 | 14.46 | 0.02 |
| 3. | Sumitomo Chemi. | 473.35 | 43.72 | 23627.06 | 0.25 | 177.90 | -6.78 | 914.44 | -5.86 | 25.14 | 3249.74 | 20.16 | 540.43 | 177.90 | 7.40 | 13.91 | 0.02 |
| 4. | Bayer Crop Sci. | 4508.10 | 33.27 | 20260.34 | 2.77 | 152.70 | 12.03 | 1553.40 | -10.60 | 24.80 | 5571.80 | 13.37 | 608.90 | 152.70 | 6.49 | 11.56 | 0.03 |
| 5. | Sharda Cropchem | 830.40 | 16.58 | 7491.91 | 1.08 | 74.35 | 75.22 | 929.11 | 19.59 | 16.50 | 4671.78 | 16.40 | 451.81 | 74.31 | 2.80 | 6.84 | 0.00 |
| 6. | Rallis India | 269.50 | 30.69 | 5240.94 | 0.93 | 102.00 | -0.39 | 861.00 | -7.22 | 10.12 | 2770.00 | 11.84 | 170.77 | 97.62 | 2.55 | 4.15 | 0.03 |
| 7. | Dhanuka Agritech | 1133.00 | 18.24 | 5107.37 | 0.18 | 93.97 | -20.04 | 598.25 | -8.56 | 28.29 | 2013.83 | 20.12 | 280.01 | 93.97 | 3.31 | 17.27 | 0.02 |
| – | Median: 24 Co. | 309.18 | 30.69 | 1799.88 | 0.16 | 19.0 | 1.1 | 402.1 | 5.38 | 12.95 | 1300.39 | 11.14 | 37.32 | 18.88 | 2.52 | 5.36 | 0.29 |
Standalone figures in ₹ crores
| Dec 2022 | Dec 2023 | Dec 2024 | Jun 2023 | Jun 2024 | Jun 2025 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 753 | 540 | 622 | 724 | 832 | 1,048 | 652 | 664 | 665 | 1,122 | 903 | 971 | 914 |
Expenses | 632 | 474 | 521 | 643 | 670 | 828 | 571 | 526 | 548 | 843 | 715 | 729 | 697 |
Operating Profit | 121 | 66 | 101 | 81 | 162 | 220 | 81 | 139 | 117 | 278 | 188 | 242 | 217 |
Other Income | 13 | 27 | 31 | 18 | 26 | 39 | 17 | 27 | 31 | 11 | 25 | 31 | 39 |
Profit before tax | 121 | 76 | 113 | 83 | 173 | 242 | 82 | 149 | 132 | 272 | 196 | 257 | 238 |
Tax % | 25% | 27% | 25% | 26% | 26% | 26% | 12% | 26% | 25% | 26% | 27% | 26% | 25% |
Net Profit | 91 | 55 | 84 | 62 | 128 | 180 | 72 | 109 | 98 | 202 | 144 | 191 | 178 |
EPS in Rs | 1.82 | 1.10 | 1.69 | 1.24 | 2.57 | 3.60 | 1.45 | 2.19 | 1.97 | 4.05 | 2.88 | 3.82 | 3.56 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 635 | 671 | 724 | 799 | 1,911 | 2,223 | 2,423 | 2,643 | 3,060 | 3,511 | 2,833 | 3,090 | 3,250 |
Expenses | 587 | 614 | 635 | 698 | 1,691 | 1,932 | 2,088 | 2,155 | 2,458 | 2,843 | 2,358 | 2,467 | 2,595 |
Operating Profit | 48 | 57 | 89 | 101 | 219 | 291 | 335 | 488 | 603 | 668 | 474 | 623 | 655 |
Other Income | 3 | 8 | 26 | 10 | 31 | -0 | -20 | 19 | 36 | 45 | 96 | 119 | 140 |
Interest | 2 | 1 | 1 | 1 | 5 | 5 | 7 | 7 | 8 | 6 | 5 | 6 | 6 |
Depreciation | 6 | 6 | 7 | 7 | 24 | 28 | 41 | 47 | 45 | 52 | 61 | 63 | 65 |
Profit before tax | 43 | 58 | 107 | 103 | 221 | 258 | 267 | 453 | 586 | 655 | 503 | 674 | 724 |
Net Profit | 33 | 35 | 65 | 62 | 145 | 167 | 206 | 345 | 434 | 503 | 370 | 502 | 540 |
EPS in Rs | – | – | – | – | – | – | 4.12 | 6.92 | 8.69 | 10.09 | 7.41 | 10.06 | 10.82 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 38% | 18% | 12% | 12% | 12% | 80% | 12% | – |
Standalone figures in ₹ crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 233 | 233 | 233 | 275 | 275 | 275 | 499 | 499 | 499 | 499 | 499 | 499 | 499 |
Reserves | -36 | -2 | 63 | 360 | 665 | 761 | 710 | 1,029 | 1,425 | 1,881 | 1,941 | 2,397 | 2,695 |
Borrowings | 0 | 0 | 0 | 0 | 10 | 20 | 36 | 33 | 38 | 34 | 25 | 45 | 49 |
Other Liabilities | 243 | 234 | 280 | 288 | 695 | 791 | 848 | 1,097 | 1,047 | 955 | 822 | 988 | 1,158 |
Total Liabilities | 440 | 466 | 576 | 922 | 1,644 | 1,846 | 2,093 | 2,658 | 3,009 | 3,368 | 3,287 | 3,930 | 4,401 |
Fixed Assets | 47 | 51 | 52 | 53 | 267 | 279 | 319 | 309 | 390 | 430 | 489 | 482 | 487 |
Gross Block | 102.27 | 109.75 | 102.40 | 106.62 | 305.76 | 345.15 | 425.48 | 460.94 | 582.08 | 670.60 | 737.75 | 777.23 | – |
Accumulated Depreciation | 55.23 | 59.09 | 50.22 | 54.08 | 39.04 | 65.96 | 106.09 | 151.67 | 191.77 | 240.81 | 249.11 | 295.36 | – |
CWIP | 0 | 0 | 1 | 7 | 9 | 8 | 10 | 14 | 35 | 71 | 23 | 28 | 14 |
Investments | 0 | 0 | 0 | 277 | 2 | 1 | 87 | 291 | 357 | 239 | 425 | 601 | 1,292 |
Other Assets | 393 | 415 | 523 | 585 | 1,367 | 1,558 | 1,676 | 2,043 | 2,227 | 2,628 | 2,351 | 2,819 | 2,608 |
Total Assets | 440 | 466 | 576 | 922 | 1,644 | 1,846 | 2,093 | 2,658 | 3,009 | 3,368 | 3,287 | 3,930 | 4,401 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operating Activity | 20 | 4 | 52 | -21 | 49 | 75 | 222 | 424 | 223 | 389 | 756 | 459 |
Cash from Investing Activity | -8 | -8 | -5 | -289 | -40 | -35 | -118 | -282 | -281 | -327 | -426 | -404 |
Cash from Financing Activity | -1 | 0 | -0 | 276 | 7 | -65 | -61 | -47 | -63 | -73 | -331 | -66 |
Net Cash Flow | 11 | -4 | 47 | -34 | 16 | -26 | 43 | 95 | -120 | -10 | -1 | -11 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 90 | 83 | 92 | 101 | 105 | 110 | 128 | 117 | 101 | 98 | 91 | 90 |
Inventory Days | 125 | 135 | 169 | 191 | 202 | 193 | 133 | 185 | 198 | 157 | 135 | 154 |
Days Payable | 134 | 109 | 132 | 115 | 176 | 136 | 112 | 145 | 110 | 87 | 96 | 107 |
Cash Conversion Cycle | 81 | 109 | 130 | 177 | 131 | 167 | 150 | 157 | 189 | 168 | 131 | 136 |
Working Capital Days | 58 | 69 | 79 | 113 | 113 | 116 | 109 | 95 | 127 | 136 | 173 | 183 |
ROCE % | 25% | 27% | 41% | 22% | 29% | 27% | 26% | 33% | 34% | 30% | 21% | 25% |
Direct from BSE filings, auto-summarised
External media mentions & references
Nov 2025
Aug 2025
Jun 2025
Jan 2025
Nov 2024
Jul 2024
Jun 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Feb 2023
Nov 2022
Aug 2022
Aug 2022
Jun 2022
Feb 2022
Nov 2021
Aug 2021
Jun 2021
Feb 2021
Nov 2020
Aug 2020
Jun 2020
Feb 2020
Stock Analysis
Corporate Announcements